E. Magnus Ohman, MD : Hello . I'm Magnus Ohman. Welcome to another edition of Life and Times of Leading Cardiologists. We are very fortunate to have a great contributor of science in cardiovascular medicine, Prof Gilles Montalescot. He is from Paris and Sorbonne University, which is world-famous, of course. Welcome.
Gilles Montalescot, MD, PhD: Thank you very much. It's wonderful to be here.
Dr Ohman: You have had a very distinguished career, mostly focused around thrombosis, and we will talk a little bit about that later. Many of us have wondered: Where did Gilles come from and where did he grow up?
The Journey Begins in Paris
Prof Montalescot: I was born and raised in Paris—a nice city to grow up in. Actually, my family originates from the center of France, from what we call Limousin, which is in Périgord. It's a region of lakes and forests.
Dr Ohman: Famous for truffles?
Prof Montalescot: It's famous for truffles and mushrooms. It's kind of a wild area. The name "Montalescot" comes from the name of a village, and the family comes from here. Actually, my grandfather was in Périgord, and the first one to move to Paris was my father. My grandfather was a small farmer—two or three cows, one pig, and cultivating a few acres, and trying to survive in this region.
Pediatric Thromboembolism
Thromboembolism in Pregnancy
COMMENTARY
Life and Times of Leading Cardiologists: Gilles Montalescot
E. Magnus Ohman, MD; Gilles Montalescot, MD, PhD
DisclosuresJanuary 18, 2018
E. Magnus Ohman, MD : Hello . I'm Magnus Ohman. Welcome to another edition of Life and Times of Leading Cardiologists. We are very fortunate to have a great contributor of science in cardiovascular medicine, Prof Gilles Montalescot. He is from Paris and Sorbonne University, which is world-famous, of course. Welcome.
Gilles Montalescot, MD, PhD: Thank you very much. It's wonderful to be here.
Dr Ohman: You have had a very distinguished career, mostly focused around thrombosis, and we will talk a little bit about that later. Many of us have wondered: Where did Gilles come from and where did he grow up?
The Journey Begins in Paris
Prof Montalescot: I was born and raised in Paris—a nice city to grow up in. Actually, my family originates from the center of France, from what we call Limousin, which is in Périgord. It's a region of lakes and forests.
Dr Ohman: Famous for truffles?
Prof Montalescot: It's famous for truffles and mushrooms. It's kind of a wild area. The name "Montalescot" comes from the name of a village, and the family comes from here. Actually, my grandfather was in Périgord, and the first one to move to Paris was my father. My grandfather was a small farmer—two or three cows, one pig, and cultivating a few acres, and trying to survive in this region.
© 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Life and Times of Leading Cardiologists: Gilles Montalescot - Medscape - Jan 18, 2018.
Tables
References
Authors and Disclosures
Authors and Disclosures
Authors
E. Magnus Ohman, MD
Professor of Medicine, Division of Cardiovascular Medicine; Vice-Chair, Department of Medicine, Development and Innovation; Kent and Siri Rawson Director, Duke Program for Advanced Coronary Disease; Associate Director, Duke Heart Center, Duke University Medical Center, Durham, North Carolina
Disclosure: E. Magnus Ohman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Abbott Vascular; ABIOMED; AstraZeneca Pharmaceuticals LP; Biotie Therapies; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo; Faculty Connection, LLC; Merck & Co; St. Jude Medical; Stealth Peptides; The Medicines Company; Medscape Received research grant from: Daiichi Sankyo; Gilead Sciences Inc; Janssen Pharmaceutical Products, L.P.
Received income in an amount equal to or greater than $250 from: ABIOMED; AstraZeneca Pharmaceuticals LP; Biotie Therapies; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo; Faculty Connection, LLC; Gilead Sciences Inc; Janssen Pharmaceutical Products, L.P.; Stealth Peptides; The Medicines Company; Medscape
Gilles Montalescot, MD, PhD
Professor, Department of Cardiology, University Sorbonne-Paris-6; Chief, Department of Cardiology, Pitié-Salpêtrière Hospital, Paris, France
Disclosure: Gilles Montalescot, MD, PhD, has disclosed the following relevant financial relationships:
Received research grant from: Actelion Pharmaceuticals, Ltd; Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Beth Israel Deaconess Medical Center; Boehringer Ingelheim Pharmaceuticals, Inc.; Brigham and Women’s Hospital; Bristol-Myers Squibb Company; BIOTRONIK; Cardiovascular Research Foundation; CCC; Celladon; CME Resources; Daiichi Sankyo, Inc.; Eli Lilly and Company; Elsevier; Europa; French Federation of Cardiology; ICAN; INSERM; Lead-Up; Medtronic, Inc.; Menarini Group; Merck Sharp & Dohme Corp.; Pfizer Inc.; sanofi-aventis; SERVIER; TIMI Study Group; WebMD, LLC